Healthcare Series B Business Plan Template
Comprehensive business plan template for healthcare and biotech companies ready to raise Series B funding ($10M-$50M). Focus on clinical validation, regulatory pathways, and market access strategies.
Series B Focus Areas for Healthcare Companies
Clinical & Regulatory Excellence
- Clinical Trial ResultsPhase II/III data demonstrating efficacy and safety
- Regulatory StrategyClear path to FDA/EMA approval and market authorization
- KOL EngagementKey opinion leader support and clinical advisory board
Commercial Readiness
- Market Access StrategyPayer relations, reimbursement strategy, and health economics
- Commercial InfrastructureSales team, distribution channels, and market penetration
- Revenue DiversificationMultiple indications, products, and revenue streams
What's Included in This Template
Executive Summary
Series B-focused summary highlighting clinical achievements and commercial potential
Market Analysis
Healthcare market sizing, competitive landscape, and unmet medical needs
Product & Technology
Technology platform, product pipeline, and intellectual property portfolio
Clinical Development
Clinical trial results, regulatory strategy, and development timeline
Regulatory Strategy
FDA/EMA pathway, regulatory milestones, and compliance framework
Commercial Strategy
Go-to-market plan, payer strategy, and revenue projections
Financial Projections
5-year financial model with clinical development costs and revenue forecasts
Funding Requirements
Series B funding strategy, clinical trial funding, and commercial launch capital
Risk Assessment
Clinical, regulatory, and commercial risks with mitigation strategies
Frequently Asked Questions
What clinical data do I need for healthcare Series B funding?
Typically Phase II data showing proof-of-concept, safety profile, and preliminary efficacy. For medical devices, clinical validation studies and early commercial traction. The data should demonstrate clear differentiation and market potential.
How should I present regulatory strategy for Series B investors?
Present clear regulatory pathway with FDA/EMA pre-submission meetings, regulatory counsel engagement, and realistic timelines. Address potential regulatory risks and show proactive regulatory strategy that de-risks the investment.
What market access considerations are crucial for healthcare Series B?
Focus on payer strategy, reimbursement pathways, health economics data, and market access partnerships. Show understanding of healthcare purchasing decisions and evidence generation requirements for market adoption.
How do I address the long development timeline in healthcare?
Present multiple value creation milestones, de-risking events, and potential exit opportunities. Show how clinical progress, regulatory achievements, and commercial traction create value independent of final product approval.